Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-04 06:57 am Purchase |
2020-07-20 | 13G | Telesis Bio, Inc. TBIO |
SANOFI SYNTHELABO SA | 271,357 6.600% |
271,357 (New Position) |
Filing History |
| 2021-02-01 08:17 am Purchase |
2020-12-31 | 13G | Sanofi SNY |
BLACKROCK INC BLK |
93,851,532 7.500% |
11,949,247 (+14.59%) |
Filing |
| 2020-06-17 5:10 pm Sale |
2020-06-12 | 13D | Regeneron Pharmaceuticals, Inc. REGN |
SANOFI SYNTHELABO SA | 279,766 0.300% |
-22,941,685 (-98.80%) |
Filing History |
| 2020-05-29 4:15 pm Sale |
2020-05-25 | 13D | Regeneron Pharmaceuticals, Inc. REGN |
SANOFI SYNTHELABO SA | 23,221,451 21.000% |
-128,914 (-0.55%) |
Filing History |